Agensys, Inc. clinical trials
Acquired by Astellas Pharma Inc
The registry lists 2 studies whose lead sponsor is Agensys, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 1, 2024.
Registry sponsor names on this page
- Agensys, Inc.2 studies
Something wrong with this grouping? Tell us on the Astellas Pharma Inc page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Astellas Pharma Inc studies →
- A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary HistologyCompletedNCT01672775Phase 1
Sponsor listed in the registry: Agensys, Inc. · Agensys, Inc. — acquired company within the Astellas Pharma Inc group
- A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002CompletedNCT01608711Phase 2
Sponsor listed in the registry: Agensys, Inc. · Agensys, Inc. — acquired company within the Astellas Pharma Inc group